PharmaShots | Incisive News in 3 Shots

Subscribe Now

Valneva

PharmaShots' Key Highlights of Third Quarter 2024

PharmaShots' Key Highlights of Third Quarter 2024

October 1, 2024

PharmaShots Weekly Snapshots (September 02 – September 06, 2024)

PharmaShots Weekly Snapshots (September 02 – September 06, 2024)

September 6, 2024

PharmaShots Weekly Snapshots (July 29 – August 02, 2024)

PharmaShots Weekly Snapshots (July 29 – August 02, 2024)

August 2, 2024

PharmaShots Weekly Snapshots (September 04–08, 2023)

PharmaShots Weekly Snapshots (September 04–08, 2023)

September 9, 2023

Pfizer and Valneva Report Partial Discontinuation of Patient Evaluation in P-III Clinical Trial for VLA15 to Treat Lyme Disease

Pfizer and Valneva Report Partial Discontinuation of Patient Evaluation in P-III Clinical Trial for VLA15 to Treat Lyme Disease

February 20, 2023

PharmaShots Weekly Snapshots (August 29 – September 02, 2022)

PharmaShots Weekly Snapshots (August 29 – September 02, 2022)

September 2, 2022

Contact Us

First Floor, B-66, Sector 63 Noida, Uttar Pradesh, INDIA - 201301
+91-120 428 0707
connect@pharmashots.com
Newsletter

Our Information

Follow Us